GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (OTCPK:POLBF) » Definitions » Dividends per Share

POLBF (Poolbeg Pharma) Dividends per Share : $0.00 (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Poolbeg Pharma Dividends per Share?

Poolbeg Pharma's dividends per share for the six months ended in Jun. 2024 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2024 was 0.00. As of today, Poolbeg Pharma's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Poolbeg Pharma Dividends per Share Historical Data

The historical data trend for Poolbeg Pharma's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Dividends per Share Chart

Poolbeg Pharma Annual Data
Trend Dec21 Dec22 Dec23
Dividends per Share
- - -

Poolbeg Pharma Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Dividends per Share Get a 7-Day Free Trial - - - - -

Competitive Comparison of Poolbeg Pharma's Dividends per Share

For the Biotechnology subindustry, Poolbeg Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Poolbeg Pharma's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poolbeg Pharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Poolbeg Pharma's Dividend Yield % falls into.


;
;

Poolbeg Pharma Dividends per Share Calculation

Dividends paid to per common share.


Poolbeg Pharma  (OTCPK:POLBF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Poolbeg Pharma's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ -0.006
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Poolbeg Pharma Dividends per Share Related Terms

Thank you for viewing the detailed overview of Poolbeg Pharma's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Poolbeg Pharma Business Description

Traded in Other Exchanges
Address
42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX
Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.